Diagnosis and Treatment of Polycystic Ovary Syndrome in Primary Care

被引：1
作者：
Tremblay-Davis, April C. [1 ]
Holley, Sharon L. [2 ,3 ]
Downes, Laurie A. [4 ]
机构：
[1] Valley Med Grp, Amherst, MA 01002 USA
[2] Baystate Med Ctr, Div Midwifery, Springfield, MA USA
[3] Baystate Midwifery Educ Program, Springfield, MA USA
[4] Elms Coll, Chicopee, MA USA
来源：
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2021年 / 17卷 / 10期
关键词：
assessment; diagnosis; PCOS; PCOS diagnostic criteria; PCOS evidence-based guidelines; polycystic ovary syndrome; Rotterdam criteria; MANAGEMENT; WOMEN;
D O I：
10.1016/j.nurpra.2021.08.008
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Polycystic ovarian syndrome affects between 6% and 18% of women of reproductive age worldwide. This syndrome can lead to female hyperandrogenism, insulin resistance, and female infertility. The Rotterdam criteria is used to improve timely diagnosis and treatment. A detailed physical examination, laboratory testing, and ultrasound imaging help diagnose this condition. Treatment is based on individual needs and should include lifestyle modifications, medication, health screening, and patient education. The goal of care should be to provide an accurate diagnosis of polycystic ovarian syndrome so that a treatment plan can be developed and implemented based on individual needs. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码：1226 / 1229
页数：4
相关论文
共 28 条
  • [1] Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
    Amiri, Mina
    Tehrani, Fahimeh Ramezani
    Bidhendi-Yarandi, Razieh
    Behboudi-Gandevani, Samira
    Azizi, Fereidoun
    Carmina, Enrico
    [J]. HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 22 - 34
  • [2] Screening and Management of the Hyperandrogenic Adolescent
    Yoost, Jennie
    Savage, Ashlyn
    [J]. OBSTETRICS AND GYNECOLOGY, 2019, 134 (04) : E106 - E114
  • [3] Polycystic ovary syndrome: a reproductive and metabolic web of risk, comorbidities, and disease
    Bates, G. Wright, Jr.
    [J]. FERTILITY AND STERILITY, 2019, 111 (03) : 471 - 472
  • [4] Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes
    Berni, Thomas R.
    Morgan, Christopher L.
    Berni, Ellen R.
    Rees, D. Aled
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (06) : 2116 - 2125
  • [5] Centers for Disease Control and Prevention, 2020, PCOS POL OV SYNDR DI
  • [6] Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome
    Dokras, Anuja
    Saini, Shailly
    Gibson-Helm, Melanie
    Schulkin, Jay
    Cooney, Laura
    Teede, Helena
    [J]. FERTILITY AND STERILITY, 2017, 107 (06) : 1380 - +
  • [7] Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews
    Gilbert, Emily W.
    Tay, Chau T.
    Hiam, Danielle S.
    Teede, Helena J.
    Moran, Lisa J.
    [J]. CLINICAL ENDOCRINOLOGY, 2018, 89 (06) : 683 - 699
  • [8] Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis
    Yilmaz, Bulent
    Vellanki, Priyathama
    Ata, Baris
    Yildiz, Bulent Okan
    [J]. FERTILITY AND STERILITY, 2018, 109 (02) : 356 - +
  • [9] A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
    Jamil, Avin S.
    Alalaf, Shahla K.
    Al-Tawil, Namir G.
    Al-Shawaf, Talha
    [J]. REPRODUCTIVE HEALTH, 2015, 12
  • [10] Jayashree S, 2019, INT J REPROD CONTRAC, V8, P63
123